During the past decade, ICON Early Phase Unit conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "ICON Early Phase Unit" are "Sickle Cell Disease" (2 trials), "Coccidioidomycosis" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Fungal Infection" (1 trials) and "Healthy" (1 trials). Many other conditions were trialed in "ICON Early Phase Unit" in a lesser frequency.

Most popular intervention types in "ICON Early Phase Unit" are "Drug" (6 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "GBT440" (2 trials), "IW-1701" (1 trials), "IW-1973" (1 trials) and "Matching Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "ICON Early Phase Unit" are 6 trials for "All" genders.

Currently, there are NaN active trials in "ICON Early Phase Unit". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in ICON Early Phase Unit, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in ICON Early Phase Unit, 5 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".